Optimizing CMV prevention after allogenic hematopoietic stem cell transplantation: using CMV-specific cellular

Sisi Zhen1,2, Xin Chen1,2, Sizhou Feng1,2

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300020, China.

Abstract

No abstract available in PubMed .